Drug Design Development And Therapy

Drug Design Development And Therapy英文簡介

Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.

The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.

Specific topics covered by the journal include:

Drug target identification and validation

Phenotypic screening and target deconvolution

Biochemical analyses of drug targets and their pathways

New methods or relevant applications in molecular/drug design and computer-aided drug discovery*

Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)

Structural or molecular biological studies elucidating molecular recognition processes

Fragment-based drug discovery

Pharmaceutical/red biotechnology

Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**

Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development

Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)

Preclinical development studies

Translational animal models

Mechanisms of action and signalling pathways

Toxicology

Gene therapy, cell therapy and immunotherapy

Personalized medicine and pharmacogenomics

Clinical drug evaluation

Patient safety and sustained use of medicines.

Drug Design Development And Therapy中文簡介

《Drug Design Development And Therapy》是一本由DOVE MEDICAL PRESS LTD出版商出版的專業(yè)醫(yī)學期刊，該刊創(chuàng)刊于2007年，刊期1 issue/year，該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學科：醫(yī)學 3區(qū)，小類學科：藥物化學 3區(qū)；藥學 3區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q2。該刊發(fā)文范圍涵蓋藥物化學等領(lǐng)域，旨在及時、準確、全面地報道國內(nèi)外藥物化學工作者在該領(lǐng)域取得的最新研究成果、工作進展及學術(shù)動態(tài)、技術(shù)革新等，促進學術(shù)交流，鼓勵學術(shù)創(chuàng)新。2021年影響因子為4.319，平均審稿速度>12周，或約稿。

中科院分區(qū)最新升級版（當前數(shù)據(jù)版本：2021年12月最新升級版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	3區(qū)	CHEMISTRY, MEDICINAL 藥物化學 PHARMACOLOGY & PHARMACY 藥學	3區(qū) 3區(qū)	否	否

中科院分區(qū)最新基礎(chǔ)版（當前數(shù)據(jù)版本：2021年12月最新基礎(chǔ)版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	3區(qū)	CHEMISTRY, MEDICINAL 藥物化學 PHARMACOLOGY & PHARMACY 藥學	3區(qū) 3區(qū)	否	否

中科院JCR分區(qū)歷年趨勢圖

JCR分區(qū)（當前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學科	分區(qū)	影響因子
Q2	PHARMACOLOGY & PHARMACY	Q2	4.319
	CHEMISTRY, MEDICINAL	Q2

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
4.319	48	95.22%	80.37%	開放	>12周，或約稿

IF值(影響因子)趨勢圖